Transforming COPD Care: Cardiopulmonary risk in COPD
This is a promotional symposium sponsored and organised by AstraZeneca intended for UK HCPs only.
- COPD burden and the risk of premature mortality
- Uncontrolled COPD might increase the risk of cardiopulmonary events.
- Guidelines on COPD pharmacotherapy